Realta Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,395
Closed -$518K 332
2024
Q4
$518K Sell
1,395
-8
-0.6% -$3.35K 0.21% 103
2024
Q3
$714K Sell
1,403
-1,435
-51% -$767K 0.33% 72
2024
Q2
$1.54M Buy
2,838
+120
+4% +$63.4K 0.3% 74
2024
Q1
$1.41M Buy
2,718
+36
+1% +$17.9K 0.29% 82
2023
Q4
$1.26M Buy
2,682
+5
+0.2% +$2.31K 0.29% 86
2023
Q3
$1.19M Hold
2,677
0.27% 85
2023
Q2
$1.19M Buy
2,677
+521
+24% +$240K 0.26% 87
2023
Q1
$991K Buy
2,156
+251
+13% +$119K 0.24% 106
2022
Q4
$977K Buy
1,905
+15
+0.8% +$7.62K 0.24% 103
2022
Q3
$859K Buy
1,890
+1,296
+218% +$620K 0.23% 114
2022
Q2
$289K Buy
594
+180
+43% +$89K 0.07% 277
2022
Q1
$204K Buy
+414
New +$189K 0.04% 394
2020
Q1
Sell
-63
Closed -$19K 603
2019
Q4
$19K Buy
63
+16
+34% +$4.4K 0.01% 940
2019
Q3
$11K Sell
47
-444
-90% -$122K ﹤0.01% 1084
2019
Q2
$139K Buy
491
+444
+945% +$121K 0.04% 410
2019
Q1
$13K Buy
+47
New +$13.6K 0.01% 857

Other funds holding ELV

Realta Investment Advisors's ELV Position: Q1 2025 in Review

Realta Investment Advisors sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1,395 shares — an estimated $518K sold.

Realta Investment Advisors first reported a position in ELV in Q1 2019 and held it in 16 quarters. The position peaked at $1.54M in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Realta Investment Advisors reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Realta Investment Advisors sold 1,395 Elevance Health shares in Q1 2025, an estimated $518K.
  • Realta Investment Advisors first reported a position in Elevance Health in Q1 2019 and held it in 16 quarters.
  • Realta Investment Advisors's Elevance Health position peaked at $1.54M in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Realta Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.